Director, 10% Owner · ACTUATE THERAPEUTICS, INC. · ACTUATE THERAPEUTICS, INC. — Warrant (Right to Buy)
Side
A
Value
—
Shares
368.3K
Price
—
Executed
Oct 28, 2026
Disclosed
Oct 30, 2026
Disclosure timeline2 days from execution to publication · legal deadline 2 business days
Oct 28 executedOct 30, 2026 disclosed
ACTU · daily
Yahoo Finance chart API
◉This trade, on the day it was made▼Disclosure●Material company filing◯Other disclosed buy◯Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Grant or award — administrative, little informational value
Relative size+1 / 25
No reported dollar value · new position
Filing timing0 / 15
Disclosed 2 business days after execution (deadline: 2)
Historical behavior+8 / 15
First recorded trade by this actor in this security
Frequency & clustering0 / 15
No clustered activity in the dataset
Market events0 / 10
No material company filing within 60 days after the trade
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
ACTUATE THERAPEUTICS, INC. — Warrant (Right to Buy)
Ticker
ACTU
Shares
368.3K
Price per share
$0
Execution date (reported)
Oct 28, 2026
Owned after transaction
368.3K shares
Days from execution to publication
2
What this establishes
BIOS Fund III, LP filed this Form 4 reporting a grant or award of ACTU on Oct 28, 2026. It became public on Oct 30, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
Director, 10% Owner
BIOS Fund III, LPcik:0001791917
Issuer
ACTUATE THERAPEUTICS, INC.cik:0001652935
Revision history · 0
No field has changed since this record was first ingested.
